IE
ALGS icon

Israel Englander’s Aligos Therapeutics ALGS Stock Holding History

Israel Englander’s Portfolio ALGS Stock Details ALGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,315
Closed -$88.8K – 5989
2025
Q2 		$88.8K Buy
+12,315
New +$73.7K ﹤0.01% 5526
2024
Q3 		– Sell
-1,195
Closed -$10.5K – 6053
2024
Q2 		$10.5K Sell
1,195
-3,231
-73% -$56.8K ﹤0.01% 5605
2024
Q1 		$108K Buy
4,426
+3,278
+286% +$65.3K ﹤0.01% 5555
2023
Q4 		$19.1K Sell
1,148
-2,524
-69% -$43.4K ﹤0.01% 5641
2023
Q3 		$68.6K Sell
3,672
-3,363
-48% -$74.5K ﹤0.01% 5421
2023
Q2 		$171K Sell
7,035
-9,100
-56% -$244K ﹤0.01% 5179
2023
Q1 		$353K Buy
16,135
+1,282
+9% +$49K ﹤0.01% 4807
2022
Q4 		$354K Buy
14,853
+1,568
+12% +$39.5K ﹤0.01% 4975
2022
Q3 		$365K Sell
13,285
-5,291
-28% -$176K ﹤0.01% 5217
2022
Q2 		$562K Buy
+18,576
New +$631K ﹤0.01% 4858
2022
Q1 		– Sell
-925
Closed -$275K – 6849
2021
Q4 		$275K Sell
925
-1,873
-67% -$683K ﹤0.01% 5630
2021
Q3 		$1.08M Buy
+2,798
New +$1.11M ﹤0.01% 4582
2021
Q2 		– Sell
-1,303
Closed -$741K – 6471
2021
Q1 		$741K Buy
+1,303
New +$867K ﹤0.01% 4485

Other funds holding ALGS

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Israel Englander's ALGS Position: Q3 2025 in Review

Israel Englander sold out of Aligos Therapeutics (ALGS) in Q3 2025, closing a stake of 12,315 shares — an estimated $88.8K sold.

Israel Englander first reported a position in ALGS in Q1 2021 and held it in 13 quarters. The position peaked at $1.08M in Q3 2021. 33 funds tracked by Wall St. Rank hold ALGS as of Q3 2025.

  • Israel Englander reported no remaining Aligos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Israel Englander sold 12,315 Aligos Therapeutics shares in Q3 2025, an estimated $88.8K.
  • Israel Englander first reported a position in Aligos Therapeutics in Q1 2021 and held it in 13 quarters.
  • Israel Englander's Aligos Therapeutics position peaked at $1.08M in Q3 2021.
  • 33 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q3 2025.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.